Affibody是一家处于瑞典临床临床阶段的私有生物技术公司，致力于基于其*的专有技术平台（Affibody®分子和Albumod™）开发利用下一代生物疗法的综合生物制药公司。
该公司经营着眼于重点的实验医学模型，目前拥有三个临床阶段计划。前两个是分别针对牛皮癣和B细胞驱动的自身免疫性疾病的治疗方案。第三个程序是诊断成像程序，主要针对转移性乳腺癌。
Affibody与AbClon，Alexion，Biotest，Daewoong，Daiichi Sankyo，GE Healthcare和Swedish Orphan Biovitrum等多家公司保持着持续的商业关系。
Affibody AB是Patricia Industries的控股公司。
瑞典Affibody2020年价格表
| 货号 | 品名 | 规格 | 价格 | 品牌 |
| 10.2023.01.0005 | Anti-EGFR imaging agent | 500 µg | 14300 | affibody2020 |
| 10.2023.01.0001 | Anti-EGFR imaging agent | 100 µg | 3400 | affibody2020 |
| 10.1861.01.0001 | Anti-HER2, imaging agent | 100 µg | 6300 | affibody2020 |
| 10.1861.01.0005 | Anti-HER2, imaging agent | 500 µg | 29100 | affibody2020 |
| 10.2046.01.0005 | Imaging agent negative control | 500 µg | 9300 | affibody2020 |
| 10.1886.01.0001 | Anti-EGFR unconjugated | 100 µg | 3400 | affibody2020 |
| 10.1886.01.0005 | Anti-EGFR unconjugated | 500 µg | 9300 | affibody2020 |
| 10.1886.03.0001 | Anti-EGFR, fluorescein conjugated | 100 µg | 9300 | affibody2020 |
| 10.1246.04.0002 | Anti-EGFR, agarose immobilized | 200 µl | 11000 | affibody2020 |
| 10.1246.04.9002 | Anti-EGFR, IP kit | 200 µl | 12300 | affibody2020 |
| 10.0817.01.0001 | Anti-HER2, unconjugated | 100 µg | 3400 | affibody2020 |
| 10.0817.01.0005 | Anti-HER2, unconjugated | 500 µg | 9300 | affibody2020 |
| 10.0817.02.0001 | Anti-HER2, biotin conjugated | 100 µg | 9300 | affibody2020 |
| 10.0817.03.0001 | Anti-HER2, fluorescein conjugated | 100 µg | 9300 | affibody2020 |
| 10.0817.04.0002 | Anti-HER2, agarose immobilized | 200 µl | 11000 | affibody2020 |
| 10.0817.04.9002 | Anti-HER2, IP kit | 200 µl | 12300 | affibody2020 |
| 10.0817.05.0002 | Anti-HER2, HRP conjugated | 200 µl | 9300 | affibody2020 |
| 10.0644.01.0010 | Anti-HSA, unconjugated | 1 mg | 14300 | affibody2020 |
| 10.0644.01.0050 | Anti-HSA, unconjugated | 5 mg | 49900 | affibody2020 |
| 10.0644.02.0005 | Anti-HSA, biotin conjugated | 500 µg | 14300 | affibody2020 |
| 10.1150.01.0005 | Anti-IgA, unconjugated | 500 µg | 7900 | affibody2020 |
| 10.1150.01.0050 | Anti-IgA, unconjugated | 5 mg | 49900 | affibody2020 |
| 10.0816.01.0010 | Anti-IgE, unconjugated | 1 mg | 14300 | affibody2020 |
| 10.0623.01.0010 | Anti-IgG, unconjugated | 1 mg | 14300 | affibody2020 |
| 10.0623.01.0050 | Anti-IgG, unconjugated | 5 mg | 49900 | affibody2020 |
| 10.0623.02.0005 | Anti-IgG, biotin conjugated | 500 µg | 14300 | affibody2020 |
| 10.1329.01.0005 | Anti-IgM, unconjugated | 500 µg | 9300 | affibody2020 |
| 10.1329.01.0050 | Anti-IgM, unconjugated | 5 mg | 49900 | affibody2020 |
| 10.0814.01.0010 | Anti-Insulin, unconjugated | 1 mg | 14300 | affibody2020 |
| 10.0814.01.0050 | Anti-Insulin, unconjugated | 5 mg | 49900 | affibody2020 |
| 10.0841.01.0010 | Anti-TNF-α, unconjugated | 1 mg | 14300 | affibody2020 |
| 10.0841.01.0050 | Anti-TNF-α, unconjugated | 5 mg | 49900 | affibody2020 |
| 10.0841.04.0002 | Anti-TNF-α, agarose immobilized | 200 µl | 9300 | affibody2020 |
| 10.0841.04.9002 | Anti-TNF-α, IP kit | 200 µl | 11900 | affibody2020 |
| 10.1105.01.0005 | Anti-Transferrin, unconjugated | 500 µg | 9300 | affibody2020 |
| 10.1105.01.0050 | Anti-Transferrin, unconjugated | 5 mg | 49900 | affibody2020 |
| 10.1278.01.0005 | Anti-Fibrinogen, unconjugated | 500 µg | 9300 | affibody2020 |
| 10.1278.01.0050 | Anti-Fibrinogen, unconjugated | 5 mg | 49900 | affibody2020 |
| 20.1000.01.0005 | Goat Anti-Affibody® IgG | 500 µl | 7900 | affibody2020 |